Table 1.
Clinicopathological factor | Number of cases | PDIA6a |
χ2 | p | |
---|---|---|---|---|---|
High expression | Low expression | ||||
Age | |||||
<60 | 55 | 48 | 7 | 1.717 | 0.190 |
≥60 | 114 | 90 | 24 | ||
Gender | |||||
Male | 121 | 103 | 18 | 3.419 | 0.064 |
Female | 48 | 35 | 13 | ||
Tumor size | |||||
<4 cm | 61 | 47 | 14 | 1.353 | 0.245 |
≥4 cm | 108 | 91 | 17 | ||
Pathological grading | |||||
I | 21 | 17 | 4 | 0.170 | 0.919 |
II | 134 | 109 | 25 | ||
III | 14 | 12 | 2 | ||
Histological type | |||||
LSCC | 78 | 69 | 9 | 4.478 | 0.034b |
LAD | 91 | 69 | 22 | ||
Lymph node metastasis | |||||
Positive | 92 | 81 | 11 | 5.499 | 0.019b |
Negative | 77 | 57 | 20 | ||
TNM stage | |||||
I | 54 | 37 | 17 | 10.78 | 0.005b |
II | 69 | 58 | 11 | ||
III | 46 | 43 | 3 |
Data are shown as number of cases.
Significant difference. The two tailed Pearson χ 2 test was employed to assess the correlation of PDIA6 expression with clinicalpathological factors. p value <0.05 was recognized as to be statistically significant.